Astrazeneca Phar

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE203A01020
  • NSEID: ASTRAZEN
  • BSEID: 506820
INR
8,086.00
-151.4 (-1.84%)
BSENSE

Jul 16, 04:01 PM

BSE+NSE Vol: 6.47 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAstrazeneca Phar VS Pharmaceuticals & Biotechnology
 
1D
-1.84%
0%
1W
-0.31%
0.58%
1M
-4.87%
0.49%
YTD
-10.26%
-9.43%
1Y
-12.07%
-6.59%
3Y
115.46%
16.84%
5Y
129.9%
45.25%
10Y
677.09%
177.29%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.39%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.15%
0%
-5.15%
6 Months
-2.01%
0%
-2.01%
1 Year
-12.07%
0%
-12.07%
2 Years
22.68%
0.45%
23.13%
3 Years
115.46%
1.46%
116.92%
4 Years
171.54%
2.29%
173.83%
5 Years
129.9%
2.58%
132.48%

Latest dividend: 32 per share ex-dividend date: Jul-18-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the YTD and longer periods

4
Quartile
quartile-4
QTD
0.26%
4
Quartile
quartile-4
Mar-Jun
5.88%
3
Quartile
quartile-3
Dec-Mar
-13.88%
2
Quartile
quartile-2
YTD
-10.42%
1
Quartile
quartile-1
2025
22.84%
4
Quartile
quartile-4
2024
32.88%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
0.26%
4
Quartile
quartile-4
Mar-Jun
5.88%
2
Quartile
quartile-2
Dec-Mar
-13.88%
3
Quartile
quartile-3
YTD
-10.42%
1
Quartile
quartile-1
2025
22.84%
3
Quartile
quartile-3
2024
32.88%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Astrazeneca Pharma India Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
0.26%
4
Quartile
quartile-4
Mar-Jun
5.88%
2
Quartile
quartile-2
Dec-Mar
-13.88%
3
Quartile
quartile-3
YTD
-10.42%
1
Quartile
quartile-1
2025
22.84%
2
Quartile
quartile-2
2024
32.88%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available